Isotechnika Inc. lined its coffers courtesy of a C$21.9 million (US$16 million) milestone payment following an achievement in the development of its lead product. (BioWorld Today)
Isotechnika Inc. lined its coffers courtesy of a C$21.9 million (US$16 million) milestone payment following an achievement in the development of its lead product. (BioWorld Today)
Development partners QLT Inc. and Xenova Group plc are going through a letdown after halting pivotal trials of tariquidar in non-small-cell lung cancer.(BioWorld Today)
